Not available outside of the UK & Ireland.
Biochem/physiol Actions
Diacylglycerol lipase inhibitor. Target for anti-obesity drugs.
Features and Benefits
This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This product has met the following criteria to qualify for the following awards: